reported that in advanced non-small cell lung cancer (NSCLC) patients receiving apatinib treatment, patients with TT(AA) genotype of CD274:rs2297136 had a significantly longer median PFS and OS than patients with any C(G) allele (26). This evidence concerns the gene CD274 and non-small cell lung carcinoma.